Hysterectomy versus chemotherapy for low-risk non-metastatic gestational trophoblastic neoplasia (GTN): A cost-effectiveness analysis

CONCLUSION: Compared to hysterectomy, single agent chemotherapy as a first-line treatment costs $74,526 for each additional QALY gained. Given that this cost falls below the accepted $100,000 willingness-to-pay threshold and waitlist limitations within public healthcare systems, these results support the continued use of chemotherapy as standard of care approach for low-risk GTN.PMID:38705127 | DOI:10.1016/j.ygyno.2024.04.014

Source: Gynecologic Oncology - May 5, 2024 Category: Cancer & Oncology Authors: Cristina Mitric Rashid K Sayyid Neil E Fleshner Nicole J Look Hong Genevieve Bouchard-Fortier Source Type: research